Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia

Cancer Research

Volumn 62, Issue 11, 2002, Pages 3030-3036

  Long, Delwin J ^a   Gaikwad, Amos ^a   Jaiswal, Anil K ^a   Multani, Asha ^b   Pathak, Sen ^b   Montgomery, Charles A ^c   Gonzalez, Frank J ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c LEXICON PHARMACEUTICALS INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PROTEIN P73; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD CULTURE; BONE MARROW DISEASE; CONTROLLED STUDY; GENE DISRUPTION; HYPERPLASIA; KIDNEY; LIVER; MEGAKARYOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPLEEN; THYMUS;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CHROMOSOMES; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HYPERPLASIA; MALE; MICE; MYELOPROLIFERATIVE DISORDERS; NAD(P)H DEHYDROGENASE (QUINONE); NADP; NUCLEAR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0036605993     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen
2. Regulation of genes encoding NAD(P)H: Quinone oxidoreductases
3. Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens
4. Glutathione S-transferases, structure, regulation, and therapeutic implications
5. NAD(P)H:Quinone oxidoreductase 1 (NQO1): Chemoprotection, bioactivation, gene regulation and genetic polymorphisms
6. DT-diaphorase: Possible roles in cancer chemotherapy and carcinogenesis
7. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C->T mutation and rapid fractional excretion of chlorzoxazone
8. Low NAD(P)H: Quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults
9. Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity
10. Chromosome banding techniques
11. High resolution G-banded chromosomes of the mouse
12. High-performance liquid chromatography analysis of oxidized and reduced pyridine dinucleotides in specific brain regions
13. A method for preparing freeze-clamped tissue samples for metabolite analyses
14. Role of telomeric sequences in murine radiation-induced leukemia
15. In vivo role of NAD(P)H:quinone oxidoreduetase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue
16. Poly(ADP-ribosylation) and apoptosis
17. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase I
18. Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis
19. Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences
20. Current concepts of chronic benzene toxicity. CRC Crit
21. Follow up study on the mortality and the development of leukemia in 44 pancytopenic patients with chronic exposure to benzene
22. Leukaemia in benzene workers
23. Recent advances in the metabolism and toxicity of benzene
24. Identification of ethanol-inducible P450 isozyme 3a (P45011EI) as a benzene and phenol hydroxylase
25. An interaction of benzene metabolites reproduces the myelo-toxicity observed with benzene exposure
26. Peroxidasedependent metabolism of benzene’s phenolic metabolites and its potential role in benzene toxicity and carcinogenicity
27. Induction of sister-chromatid exchanges in human lymphocytes by microsomal activation of benzene metabolites
28. Mechanism of benzene toxicity: Effects of benzene and benzene metabolites on bone marrow cellularity, number of granulopoietic stem cells and frequency of micronuclei in mice
29. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:Quinone oxidoreductase 1 (NQO1) to benzene toxicity
30. Benzene, NQO1, and genetic susceptibility to cancer
31. 609C → T polymorphism in the NAD(P)H:Quinone Oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia